Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Amgen beats Street 4Q forecasts
Yahoo/AP
Fri, 02/3/17 - 10:09 am
Tags:
Amgen, earnings
Amgen Cholesterol-Lowering Drug Repatha Cuts Heart-Related Adverse Events in Big Study
TheStreet.com
Fri, 02/3/17 - 10:06 am
Tags:
Amgen, Repatha, cholesterol
Transcript of Pharma CEOs Meeting With Trump
Investors Hub
Wed, 02/1/17 - 09:45 am
Tags:
Donald Trump, Eli Lilly, Merck, Amgen, Celgene, JNJ, Novartis, drug pricing
Pharma goes to Washington, Trump talks pricing
BioPharma Dive
Wed, 02/1/17 - 09:41 am
Tags:
pharma industry, drug pricing, Donald Trump, Eli Lilly, Amgen, Merck, Novartis, Celgene, JNJ
Key FDA Decision And Trial Dates In February
Seeking Alpha
Mon, 01/30/17 - 11:03 pm
Tags:
FDA, Amgen, Valeant Pharmaceuticals, Amphastar, Egalet, Lexicon Pharmaceuticals, Amicus Therapeutics, Axovant
Amgen Gets EU Nod for Humira Biosimilar
Investopedia
Mon, 01/30/17 - 10:54 pm
Tags:
Amgen, Humira, biosimilars, ABP 501
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Sun, 01/29/17 - 11:53 am
Tags:
Novartis, biosimilars, Zioxtenzo, Europe, Amgen, Neulasta, China
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Tags:
Novartis, Enbrel, patents, Erelzi, Amgen, biosimilars, rheumatoid arthritis
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Sat, 01/14/17 - 03:35 pm
Tags:
Amgen, Supreme Court, Neupogen, Novartis, Sandoz, biosimilars
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
Tags:
PCSK9 inhibitors, payers, Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Tags:
Regeneron, Pharma CEOs, Amgen, Sanofi, patents, Repatha, Praluent, Len Schleifer
Amgen, Immatics In Cancer Drug Partnership
Investopedia
Mon, 01/9/17 - 10:10 am
Tags:
Amgen, Immatics, bispecific antibodies, R&D, cancer
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Tags:
Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Tags:
Regeneron, Sanofi, Amgen, patents, Repatha, Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha, patents
Valeant Is A Strong Acquisition Target
Seeking Alpha
Thu, 01/5/17 - 09:36 am
Tags:
Valeant Pharmaceuticals, M&A, Gilead Sciences, Pfizer, Amgen
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, Amgen, Praluent, Repatha
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
Tags:
biotech, M&A, drug launches, Gilead Sciences, Incyte, Spinraza, Biogen, Ionis Pharmaceuticals, Amgen, Regeneron, Sanofi
Amgen: Opportunity May Be Knocking
Yahoo/GuruFocus
Mon, 01/2/17 - 11:45 am
Tags:
Amgen
Enbrel Sales Were Flat in 3Q16
Market Realist
Thu, 12/29/16 - 10:14 am
Tags:
Enbrel, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.